Beverly A. Heinz
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Viral Infections and Immunology Research, Hepatitis C virus research, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates(2021)489 cited
- → LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants(2022)456 cited
- → 2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imidazo[1,2-a]pyridines as a Novel Class of Inhibitors of Human Rhinovirus: Stereospecific Synthesis and Antiviral Activity(1998)277 cited
- → LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection(2020)174 cited
- → Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase(2000)122 cited
- → Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer’s Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective(2010)115 cited
- → Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors(2008)108 cited
- → N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes(2010)99 cited
- → Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism(2016)89 cited
- → Cytoskeletal Requirements for Hepatitis C Virus (HCV) RNA Synthesis in the HCV Replicon Cell Culture System(2003)74 cited